Select Publications
Conference Papers
, 2021, 'Patient-derived xenograft mouse models to test novel cell therapies for leukemia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 12 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693805000014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Preclinical optimization of a low cost PiggyBac transposase (PB) generated CD19-specific chimeric antigen receptor T cell (CART19) product for a first in man trial using local hospital cell manufacture', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, presented at
, 2016, 'Combined immune and epigenetic therapy for high risk and relapsed leukaemias and lymphomas', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 118 - 119, presented at
, 2016, 'Ex vivo expansion of cytolitic natural killer cells in combined immune therapy for relapsed and refractory neuroblastoma', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 131 - 131, presented at
, 2016, 'Haematopoietic stem cells to generate chimeric antigen receptor (CAR)-modified T cells', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 119 - 119, presented at
, 2016, 'Increasing stem cell dose promotes immune reconstitution following stem cell transplant', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 954 - 954, presented at
, 2016, 'HAEMATOPOIETIC STEM CELL TRANSPLANTS ENHANCE CART CELL EXPANSION AND PERSISTENCE IN XENOGRAFT MOUSE MODEL', in CYTOTHERAPY, ELSEVIER SCI LTD, pp. S61 - S61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800162&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'DECLINED PRESENTATION ONE DOSE OF 5-AZA-2 '-DEOXYCYTIDINE ENHANCES THERAPEUTIC EFFICACY OF CART-CELL THERAPY IN A MURINE MODEL BY IMPROVING T-CELL PERSISTENCE', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, JAPAN, Kyoto, pp. S59 - S59, presented at
, 2015, 'DECLINED PRESENTATION STEM CELL APPROACH TO GENERATE CHIMERIC ANTIGEN RECEPTOR MODIFIED IMMUNE EFFECTOR CELLS', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, JAPAN, Kyoto, pp. S59 - S59, presented at
, 2015, 'DECLINED PRESENTATION T-CELL PRECURSORS TO GENERATE CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELLS', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, JAPAN, Kyoto, pp. S60 - S60, presented at
, 2014, '5-Aza-2 '-Deoxycytidine Promotes Cytotoxic Effect of CART-Cells on Leukaemia Cells', in BLOOD, AMER SOC HEMATOLOGY, CA, San Francisco, presented at
, 2014, 'Stem Cell Approach to Generate Chimeric Antigen Receptor Modified Immune Effector Cells to Treat Cancer', in BLOOD, AMER SOC HEMATOLOGY, CA, San Francisco, presented at
, 2014, 'STEM CELL APPROACH TO GENERATE MULTIPLE IMMUNE EFFECTOR CELLS TO TREAT CANCER', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 32 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'INCREASING STEM CELL DOSE PROMOTES THE LONGEVITY OF THE GRAFT IN MICE TRANSPLANTED WITH HUMAN CORD BLOOD STEM CELLS', in CYTOTHERAPY, ELSEVIER SCI LTD, pp. S57 - S57, http://dx.doi.org/10.1016/j.jcyt.2014.01.206
, 2013, 'GSK-3 beta INHIBITION PROMOTES T CELL RECONSTITUTION AND PRESERVES NAIVE T CELL PHENOTYPE IN MICE TRANSPLANTED WITH HUMAN HAEMATOPOIETIC STEM CELLS', in CYTOTHERAPY, INFORMA HEALTHCARE, pp. S6 - S6, http://dx.doi.org/10.1016/j.jcyt.2013.01.020
, 2013, 'TRANSIENT INHIBITION OF GSK-3,beta PROMOTES EARLY AND LATE ENGRAFTMENT OF EX VIVO EXPANDED HAEMATOPOIETIC PROGENITOR CELLS IN IMMUNO-COMPROMISED MICE', in CYTOTHERAPY, INFORMA HEALTHCARE, pp. S22 - S22, http://dx.doi.org/10.1016/j.jcyt.2013.01.081
, 2011, 'THE POTENTIAL OF GSK3B INHIBITORS AS NOVEL THERAPEUTICS FOR GVHD', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, pp. S22 - S23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000293801700045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2011, 'THERAPEUTIC TARGETING OF GSK3B MAY BECOME A STRATEGY IN PATIENTS RECEIVING STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, pp. S81 - S82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000293801700136&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS SUPPRESS LEUKEMIA CELL GROWTH', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRALIA, Melbourne, pp. S48 - S48, presented at
, 2010, 'INVESTIGATING THE POTENTIAL OF PHARMACOCHEMICAL INHIBITION OF GSK3-BETA TO REDUCE THE BURDEN OF GVHD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRALIA, Melbourne, pp. S35 - S35, presented at
, 2008, 'GSK-3 beta Inhibition Activates WNT, Delays Division and Preserves the Function in Hematopoietic Stem Cell', in BLOOD, AMER SOC HEMATOLOGY, CA, San Francisco, pp. 230 - 230, presented at
, 2006, 'Glycogen synthase kinase-3 beta regulates ex-vivo expansion and engraftment of umbilical cord blood hematopietic stem cells through the activation of wnt signaling.', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, pp. 105A - 106A, presented at
, 2006, 'Mutant Ras-expressing fibroblasts induce expansion of circulating angio- and lymphangiogenic precursor cells: Potential role in tumour vascularisation.', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, pp. 389A - 389A, presented at
, 2006, 'N-ras(m)-transduced fibroblasts facilitate the expansion and engraftment of umbilical cord blood stem cells.', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, pp. 912A - 912A, presented at
, 2006, 'Novel role of activated ras in leukaemogenesis: Induction of angiogenesis.', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, pp. 385A - 385A, presented at
, 2006, 'Targeting the IRF2 transcription factor to inhibit leukaemic cell growth.', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, pp. 414A - 414A, presented at
, 2006, 'Glycogen synthase kinase-3 regulates ex vivo expansion of human umbilical cord blood progenitor cells.', in CYTOTHERAPY, TAYLOR & FRANCIS AS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239337600054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2006, 'Molecular profile and functional analysis of the molecular factors derived from ras-transduced cells that regulate hematopoiesis.', in CYTOTHERAPY, TAYLOR & FRANCIS AS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239337600259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2006, 'Novel approaches for the ex vivo expansion of the engraftable cord blood derived haematopoietic progenitor cells.', in CYTOTHERAPY, TAYLOR & FRANCIS AS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239337600043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2006, 'Stroma cells support ex vivo expansion of retrovirally transduced haematopoietic progenitor cells.', in CYTOTHERAPY, INFORMA HEALTHCARE, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239337600010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2005, 'Ras promotes engraftment of human haematopoietic stem cells through the activation of auto/paracrine mechanisms', in CYTOMETRY PART A, WILEY-LISS, AUSTRIA, Queensland, pp. 407 - 407, presented at
, 2005, 'Using a novel inhibitor of GSK-3 beta to activate the Wnt pathway in human haematopoietic stem cells: Impact on stem cell parameters', in CYTOMETRY PART A, WILEY-LISS, AUSTRIA, Queensland, pp. 415 - 416, presented at
, 2005, 'An in vivo assay for retrovirally transduced human haematopoietic stem/progenitor cells (HSC/HPC) using nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice', in JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, AUSTRALIA, Melbourne, pp. 1135 - 1135, presented at
, 2003, 'Differential retroviral transduction of primitive hematopoietic progenitors rather than gene silencing accounts for variation in transgene expression', in JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, AUSTRALIA, QUEENSLAND INST MED RES BRISBANE, BRISBANE, pp. S13 - S14, presented at
, 2002, 'Mutant N-ras induces myeloid differentiation in human cord blood CD34+ cells', in BLOOD, AMER SOC HEMATOLOGY, PENNSYLVANIA, PHILADELPHIA, pp. 209B - 209B, presented at
, 1997, 'Tumor suppressor gene transfer as a therapeutic stratergy for hematopoietic malignancies', in Cancer genetics and tumor supprressor genes conference, Cancer genetics and tumor supprressor genes conference, Frederick, Maryland, pp. 71 - 71, presented at
, 1997, 'Ischemic preconditioning enhances preservation of rat heart during prolonged hypothermic strorage through activation of Katp channels', in Journal of Heart and Lung Transplantation, Elsevier Science Inc, New York, NY, USA, pp. 50, presented at
, 1997, 'Tumor suppressor gene transfer as a therapeutic stratergy for hematopoietic malignancies', in Australian Society of Medical research, Australian Society of Medical research, Garvan Institute, Sydney, pp. P-30, presented at